Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it ...

Neuroscientist Matthew Sacchet is revealing how mastering meditation can not only enable transcendental states of bliss, but ...

Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...

The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

Columbus Business First President & Publisher Nick Fortine speaks with experts from Trace3 and Cisco about how organizations ...

A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...

The FDA’s clearance marks a significant regulatory milestone for Jupiter, enabling the Company to begin enrollment in its exploratory Phase 2a trial designed to evaluate the safety and tolerability of ...

New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to ...

Capricor Therapeutics, Inc. ( CAPR) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Third Quarter 2025 Conference ...

Security systems fail. When it fails, what do you do?” This critical question from Spire Connect’s Pankaj Sharma set the stage at Gitex 2025 for a conversation with Francois Driessen, the “Human ...

Has zero trust lost its momentum—or are businesses just doing it wrong? In this episode of Today in Tech, host Keith Shaw sits down with Morey Haber, Chief Security Advisor at BeyondTrust and author ...